1 / 21

Wound Healing Gel

Wound Healing Gel. A Silver nanoparticle based hydrogel prepared by green synthesis. Novelty/Inventive component The product uses nanoparticle of silver formed by green synthesis Social Relevance Its an OTC product with vast market potential

alanna
Télécharger la présentation

Wound Healing Gel

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Wound Healing Gel A Silver nanoparticle based hydrogel prepared by green synthesis

  2. Novelty/Inventive component The product uses nanoparticle of silver formed by green synthesis • Social Relevance • Its an OTC product with vast market potential • Use of herbal product has better market acceptability • Hence very much required by the society • Commercial Potential The new product uses 0.02% silver nitrate while the traditional ones like Silverex® (Ranbaxy) uses 0.2% w/w. It’s a 10 times reduction in the quantity of silver used.

  3. Proof of concept: Wound healing activity in Swiss Albino Wistar Rats.

  4. PROPOSAL AIMS AT Aim: Seeking approval for further investigation regarding safety & stability of the product & conduct clinical trial Key deliverables: • Evaluation of safety & stability of the product using analytical/bio-analytical method following ICH guidelines • Evaluation of microbial load in final product & identification of suitable preservative. • Conducting Phase – I clinical trial.

  5. OBJECTIVES To establish safety, stability and efficacy through clinical trials Work Plan Step 1 – Assessment of safety of the product: Skin irritation studies will be carried out using rabbits by Drazie test. The irritancy score shall be computed and based on response of skin. Step 2 -Stability of the product: Effect of varying storage conditions on product stability/efficacy will be evaluated using suitable analytical/ bio-analytical method as per ICH guideline. Step 3 – Evaluation and reduction of microbial load: Microbial load of the formulation will be assessed and attempt will be made to reduce the microbial load by incorporating preservative at optimum concentration. Step 4 – Clinical trials: The safety/efficacy of the product will be proven through clinical trials.

  6. ENVISAGED OUTCOME OF THE STUDY • The outcome of the project would be a comparatively cost effective formulation for treatment of wound healing that will be based on newer nanotechnology. The product will demonstrate adequate stability & safety. • After successful safety & stability test and DCGI approval, this project will go to Phase-2 for clinical trail study.

  7. PRELIMINARY WORK UNDERTAKEN

  8. Microbial efficacy by Agar Well diffusion Assay

  9. Characterization of nanoparticles: UV Spectroscopy

  10. Crystallinity Studies: XRD

  11. Electron microscopy (SEM)

  12. Infrared Spectroscopy

  13. Wound healing Activity : ays 7 & 14

  14. Wound healing Activity: Days 14 & 21

  15. Preparation of formulation Silver Nitrate Addition of herbal extract Formation of colloidal nanoparticles after heating Addition of gelling polymer & preservative Allow to stand overnight Product

  16. ENVISAGED OUTCOME OF THE STUDY • The outcome of the project would be a comparatively cost effective formulation for treatment of wound healing that will be based on newer nanotechnology. The product will demonstrate adequate stability & safety. • After successful safety & stability test and DCGI approval, this project will go to Phase-2 for clinical trail study.

  17. List or marketed product

  18. RATIONALE

  19. INFORMATION REGARDING IPR • Background IP details: Complete Patent Filled • IP owned by: Chandra, A., et al. c/o Amity University, Noida • Licensing details, if any: Nil

  20. FUTURE PLANS • The success of the clinical trial would lead to the scale up, process validation, large scale manufacture and finally commercialization and marketing of the product. This activity would be taken up in the next phase.

  21. Thank You

More Related